When attempting to value banks, different rules apply. Why debt and cash are trickier concepts in the bank context. Read More

2012 is shaping up to be an "annus horribilis" for the drug industry thanks to a large number of patent expirations. Some drug stocks will thrive regardless and Jim names a few. Read More

With the Detroit Auto Show in full swing, cars are on Jim's mind. Several automobile stocks look like attractive investments, but one looks better than all the rest. Read More

Are the apocalyptic financial visions of bond king Bill Gross insightful or just a smoke screen for his own poor performance? Read More

Jim critiques James Montier's list of investment principles. For the most part, they're right on the money. Read More

The Coca-Cola Company is one of the greatest growth stocks of all time. Roberto Goizueta, who was Coke's CEO from 1980-1997, was a large part of that success. Read More

Express Scripts may not be allowed to merge with Medco, but Walgreen's latest earnings report shows that drugstores are the real losers. Read More

Warren Buffett's new-found interest in Japanese stocks is directly related to their historic cheapness. Simply put, Japan is a value investor's dream. Read More

When investing in IPOs, one needs to know how to separate the wheat from the chaff. Jim only likes two of this week's IPOs, which include the long-awaited Zynga. To find out which two IPOs may be worth your investment dollars, read on. Read More

Foreign retailers have experienced another setback in India. But several US-listed Indian companies will allow investors to tap into the rapid growth of India’s consumer culture. Read More